Key facts
| Price (PPV) | 2,265 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | mycophenolate (sodium) |
| Class | Immunosuppressants |
| ATC code | L04AA06 |
| Manufacturer | NOVARTIS PHARMA MAROC |
| Presentation | Boite 120 |
| Nature | Médicament |
| Hospital price | 1,920 MAD |
| Data collected on | 9/8/2026 |
Indications
Myfortic, en association avec la ciclosporine et les corticoïdes, est indiqué dans la prévention du rejet aigu d'organe chez les patients adultes ayant bénéficié d'une allogreffe rénale. Source : Compendium.ch - Date : 20 octobre 2025
Find an open pharmacy
On-call pharmacies near you
About Myfortic 360 mg
Myfortic 360 mg belongs to the immunosuppressants therapeutic class. In Morocco, this drug is marketed by NOVARTIS PHARMA MAROC and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Myfortic 360 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Myfortic 360 mg
Answers to common questions from Moroccan patients about this drug.